| | 
Part, Chapter, Paragraph
1 -, 1 | Organizations (Appendix 1); (iii) reviewed by the experts
2 -, 1 | Introduction; (ii) Data sources; (iii) Data description and analysis; (
3 I, 2. 1 | ii) higher labour supply;(iii) improved skills as a result
4 II, 5. 2. 7 | Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol
5 II, 5. 4. 2 | tolerance and/or diet only~2~III Risk factors for complications~ ~
6 II, 5. 5.Int | Disabilities in 2003; and (iii) The adoption of a European
7 II, 5. 5. 3 | disease progression, and iii) the majority of the cost
8 II, 5. 5. 3 | couple in the community; (iii) living or staying in nursing
9 II, 5. 6. 6 | O'Fallon WM, Melton LJ, III (1993): Population-based
10 II, 5. 6. 6 | 1005~Cooper C, Melton LJ, III (1992): Epidemiology of
11 II, 5. 6. 6 | BMJ 317:111-115~Melton LJ, III (1995): Epidemiology of
12 II, 5. 6. 6 | by: Riggs BL, Melton LJ, III). Lippincott-Raven Publishers,
13 II, 5. 6. 6 | Publishers, pp 225-47~Melton LJ, III (2003): Adverse outcomes
14 II, 5. 7.Acr | in Renal Disease~NHANES III~National Health and Nutrition
15 II, 5. 7.Acr | Nutrition Examination Survey III~PD~Peritoneal Dialysis~PMARP~
16 II, 5. 7. 1 | Nutrition Examination Survey III (NHANES III) show that about
17 II, 5. 7. 1 | Examination Survey III (NHANES III) show that about 1 out 10
18 II, 5. 7. 3 | made in the USA (NHANES III and NHANES IV performed
19 II, 5. 7. 3 | rose from 14.5% (NHANES III) to 16.8% (NHANES IV) (Tonelli
20 II, 5. 7. 7 | gender: evidence from NHANES III. Ann Epidemiol 2007 Jan;
21 II, 5. 8. 3 | respectively for stage I, II and III of the diseases.~ ~In the
22 II, 5. 8. 3(27)| FEV1 <80% predicted~Stage III:~Severe FEV1/FVC <0.70~30%
23 II, 5. 9. 2 | to 11 years. ISAAC Phase III is the continuation of this
24 II, 5. 9. 4 | pteronyssinus; (ii) timothy grass; (iii) cat; (iv) Cladosporium
25 II, 5. 9. 7 | and conjunctivitis: Phase III of the International Study
26 II, 5. 11. 6 | becoming more common; and iii) that future demand for
27 II, 7. 5 | surveillance instruments; (iii) to strengthen the technical
28 II, 9. 2. 5 | physical activity~· RPG III: ensure clean outdoor and
29 II, 9. 4. 5 | couple in the community; (iii) living or staying in an
30 III | PART III~HEALTH CAUSES, FACTORS AND
31 III, 10. 2. 1 | ii) problem drug use; (iii) drug related infectious
32 III, 10. 2. 1 | health-promoting school activities; (iii) for those countries without
33 III, 10. 2. 1 | be added to foods. Annex III is a list of substances
34 III, 10. 4. 2 | and specified in its Annex III, Chapter A. At the beginning
35 III, 10. 4. 2 | in Chapter B.I of Annex III of the TSE Regulation, Member
36 III, 10. 4. 2 | 250 substance);~· Annex III deals with temporary MRLs
37 III, 10. 4. 2 | latest draft Annexes II and III which specify the data required
38 IV, 11. 6. 5 | al. (2005): Mental health III: Funding mental health in
39 IV, 12. 4 | position July 2007)~Daphne III (combating violence against
40 IV, 12. 6 | professionals and trade unions; (iii) health service providers
41 IV, 12. 10 | ii) older people and (iii) disability and mental health
42 IV, 13. 7. 3 | European Research Council; (iii) strengthening the human
|
|
| |
